Point-of-Care Gastric Ultrasound: Should It Become the New “NPO Check”?

Introduction

Preoperative fasting has long been a fundamental component of perioperative care, with the primary objective of reducing the risk of pulmonary aspiration during anesthesia while minimizing unnecessary patient discomfort, dehydration, and metabolic stress. The traditional rationale for fasting is based on the assumption that restricting oral intake for a specified period allows adequate gastric emptying before anesthesia induction. Current fasting guidelines have evolved considerably from the historical “nothing by mouth after midnight” approach and now incorporate evidence based recommendations that permit clear liquids up to a few hours before surgery in appropriately selected patients. These modern protocols seek to balance patient safety with enhanced perioperative recovery and improved patient experience.

Conventional preoperative fasting assessment relies heavily on evaluating the timing and composition of a patient’s most recent oral intake, along with a review of medical history, procedural urgency, and known aspiration risk factors. For most healthy patients undergoing elective procedures, this approach remains effective and provides a practical framework for perioperative decision making. Standardized fasting guidelines have contributed remarkably to reducing aspiration risk while preventing the adverse consequences associated with prolonged fasting, including dehydration, insulin resistance, hunger, thirst, anxiety, and postoperative nausea.

Despite their widespread use, fasting guidelines have inherent limitations because fasting duration does not necessarily correlate with actual gastric contents at the time of anesthesia. Gastric emptying is a dynamic physiological process influenced by numerous patient specific and disease related factors. As a result, two patients who have observed identical fasting periods may have markedly different gastric volumes and compositions. This discrepancy has prompted increasing interest in methods that can provide direct assessment of gastric contents rather than relying solely on fasting history.

A wide range of clinical conditions can impair gastric emptying and increase the risk of residual gastric contents despite adherence to fasting recommendations. Acute illness, severe pain, trauma, and psychological stress can activate sympathetic pathways that slow gastrointestinal motility. Opioid medications are well recognized for their inhibitory effects on gastric emptying and gastrointestinal transit. Chronic conditions such as diabetes mellitus, particularly when associated with autonomic neuropathy, may lead to gastroparesis and unpredictable gastric function. Pregnancy introduces hormonal and mechanical changes that can delay gastric emptying and increase aspiration risk. Similarly, obesity, bowel obstruction, neurological disorders, renal failure, critical illness, and enteral feeding may notably alter gastric physiology and challenge the reliability of standard fasting protocols.

The growing use of glucagon-like peptide 1 receptor agonists has introduced an additional and increasingly important consideration in perioperative practice. These medications, widely prescribed for type 2 diabetes and obesity management, exert part of their therapeutic effect by slowing gastric emptying and promoting satiety. Although this mechanism contributes to improved glycemic control and weight reduction, it also raises concerns regarding residual gastric contents at the time of anesthesia. The effect appears particularly relevant during dose escalation phases and in patients experiencing gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, or early satiety. Consequently, anesthesiologists and perioperative teams are increasingly faced with uncertainty regarding aspiration risk in patients receiving these agents.

Against this backdrop, point of care gastric ultrasound has emerged as a valuable bedside tool for individualized aspiration risk assessment. Unlike traditional fasting evaluation, gastric ultrasound allows clinicians to directly visualize the gastric antrum and estimate both the nature and volume of gastric contents in real time. This approach provides objective information that can supplement clinical judgment and help guide perioperative decision making in situations where fasting history alone may be insufficient.

The technique primarily focuses on examination of the gastric antrum because this region is readily accessible and demonstrates predictable changes in appearance according to gastric volume. Ultrasound assessment can identify whether the stomach appears empty, contains small amounts of clear fluid, or contains solid or thick particulate material. Clear fluid generally presents with characteristic sonographic features that allow estimation of gastric volume, while solid contents or thick secretions may indicate an elevated aspiration risk. These findings provide clinically actionable information that can influence anesthetic planning and procedural management.

The greatest value of point of care gastric ultrasound lies in situations where the findings have the potential to alter clinical management. This includes patients with uncertain fasting histories, emergency surgical cases, individuals receiving medications that delay gastric emptying, and those with medical conditions associated with impaired gastrointestinal motility. In such circumstances, ultrasound findings may help determine whether a procedure can proceed safely, whether surgery should be delayed to allow further gastric emptying, or whether additional precautions are warranted.

Information obtained from gastric ultrasound can influence several aspects of anesthetic management. Clinicians may elect to proceed with the planned anesthetic approach if the stomach appears empty or contains only minimal clear fluid. Conversely, evidence of gastric contents may prompt consideration of regional anesthesia techniques when appropriate, modification of sedation strategies, gastric decompression, airway protection measures, or rapid sequence induction and intubation. In some cases, the findings may support postponement of elective procedures until aspiration risk can be reduced.

Beyond its role in aspiration prevention, gastric ultrasound reflects a broader shift toward individualized perioperative medicine. Rather than relying exclusively on population based fasting recommendations, clinicians can increasingly tailor management decisions according to each patient’s physiological status and actual gastric content. This approach aligns with modern principles of precision medicine, emphasizing risk stratification and evidence based decision making at the point of care.

Although gastric ultrasound offers promise, successful implementation requires appropriate training, standardized scanning protocols, and an understanding of its limitations. Operator expertise remains essential for accurate image acquisition and interpretation, and ultrasound findings should always be integrated with the broader clinical context rather than used in isolation. Ongoing research continues to refine assessment techniques, establish validated gastric volume thresholds, and clarify the role of gastric ultrasound in diverse surgical populations.

As perioperative medicine continues to evolve, point of care gastric ultrasound is becoming an increasingly valuable adjunct to traditional fasting assessment. By providing direct visualization of gastric contents, it addresses important limitations of conventional fasting guidelines and enhances clinicians’ ability to make informed decisions regarding aspiration risk. In an era marked by increasingly complex patient populations, expanding use of medications that affect gastric motility, and growing emphasis on personalized care, gastric ultrasound represents a key advancement in perioperative risk assessment and patient safety.

Current Fasting Guidance Still Matters

Gastric ultrasound should not be positioned as a rejection of fasting guidelines. Guidelines remain the starting point for healthy elective patients. Standard fasting recommendations are useful because they reduce variation, support scheduling, and provide a shared framework for anesthesiologists, surgeons, proceduralists, nurses, pharmacists, and patients.

However, fasting guidelines are not diagnostic tests. They estimate risk in populations, while gastric ultrasound provides patient-specific information at a specific point in time. The two approaches are complementary. A patient can meet fasting criteria and still have retained gastric contents. Another patient may have recent clear-liquid intake but an empty or low-volume stomach. The clinical issue is whether ultrasound findings are reliable, actionable, and relevant to the procedure being planned.

When Gastric Ultrasound Is Most Useful

Gastric ultrasound is most useful when fasting history is uncertain, when delayed gastric emptying is plausible, or when the consequences of aspiration are high. It is also useful when the procedure is urgent enough that waiting for guideline-based fasting intervals may create harm.

Emergency surgery is an obvious use case. The timing and content of last intake may be unknown, inaccurate, or irrelevant because surgical urgency overrides fasting intervals. Gastric ultrasound can help determine whether the patient should be managed as having a full stomach and whether anesthetic precautions should be intensified.

Obstetric anesthesia is another important area, especially active labor and urgent cesarean delivery. Gastric emptying, opioid exposure, pain, and urgency can complicate standard fasting assumptions. Gastric ultrasound may help in selected cases, although routine use for all non-laboring elective obstetric patients is not supported.

Patients with diabetes, suspected gastroparesis, prior gastric surgery, severe reflux with additional risk factors, bowel obstruction, opioid exposure, critical illness, and enteral feeding may also benefit from targeted assessment. In these groups, fasting duration alone may be less reliable.

GLP-1 Receptor Agonists and the New Aspiration-Risk Conversation

GLP-1 receptor agonists and dual incretin agents are now widely used for diabetes, obesity, and cardiometabolic risk reduction. They can delay gastric emptying and cause nausea, vomiting, bloating, early satiety, constipation, and abdominal discomfort. The perioperative question is no longer simply whether a patient took the medication. It is whether the patient has symptoms or circumstances that suggest clinically important delayed gastric emptying.

Current multisociety guidance has moved away from holding GLP-1 therapy for every patient before elective procedures. Most patients can continue therapy, while higher-risk patients may need a modified diet, anesthesia-plan adjustment, delay of elective procedures, or objective assessment such as gastric ultrasound when available and when the result would change management.

Higher-risk features include dose escalation, higher doses, active gastrointestinal symptoms, known gastroparesis, other disorders that slow gastric emptying, and combinations of risk factors. Gastric ultrasound can be useful in this setting, but it should not become a reflex test for every patient taking a GLP-1 receptor agonist.

Technique and Interpretation

Most protocols image the gastric antrum using a low-frequency curvilinear probe. The antrum is identified in the epigastrium between the liver and pancreas, usually in both the supine and right lateral decubitus positions. The right lateral decubitus position is especially useful because clear fluid pools in the dependent antrum and can be measured.

Qualitative assessment is usually the most important step. An empty antrum in both supine and right lateral decubitus positions suggests an empty stomach. Thick fluid or solid content should be treated as a full stomach. Clear fluid requires volume estimation because small amounts of clear fluid may reflect baseline gastric secretions.

A commonly used high-risk threshold is clear fluid greater than 1.5 mL/kg or any solid or thick content. This threshold is practical, but it should not be presented as an absolute biologic boundary between safe and unsafe anesthesia. Aspiration risk depends on gastric content, airway management, procedure urgency, patient comorbidities, positioning, sedation depth, and protective reflexes.

Table 1. Practical Interpretation of Gastric Ultrasound

Ultrasound finding	Typical interpretation	Practical response
Empty antrum in supine and right lateral decubitus positions	Low-risk stomach	Proceed if other clinical factors are acceptable
Small clear fluid, usually visible only in right lateral decubitus position	Likely baseline gastric secretions	Proceed in many cases; integrate with patient risk and procedure type
Clear fluid estimated >1.5 mL/kg	Higher-risk stomach	Consider delay if elective; consider aspiration precautions if urgent
Thick fluid or solid content	Full stomach	Delay elective cases or proceed with full-stomach precautions if urgent
Antrum not visualized or technically limited study	Indeterminate	Do not falsely reassure; manage based on clinical risk
Prior gastric surgery or altered anatomy	Standard formulas may not apply	Use qualitative findings cautiously and correlate clinically

Management When Gastric Ultrasound Suggests a Full Stomach

A gastric ultrasound finding suggestive of a full stomach has important implications for perioperative risk assessment and anesthetic planning, particularly because residual gastric contents are a major contributor to pulmonary aspiration during sedation and anesthesia. However, the identification of a full stomach should not automatically result in procedure cancellation. Instead, the finding should be integrated into a broader clinical assessment that considers the urgency of the procedure, the patient’s comorbidities, the nature of the gastric contents, and the risks associated with delaying treatment. Gastric ultrasound serves as a decision support tool that enhances risk stratification rather than a standalone determinant of clinical management.

The appropriate response to a full stomach finding depends largely on procedural urgency. In elective settings, postponement of the procedure is often the safest option, allowing additional fasting time and reducing aspiration risk. Delaying surgery may be particularly appropriate when solid gastric contents are identified, as solids are associated with a higher risk of clinically significant aspiration and are less amenable to pharmacologic or mechanical interventions. In contrast, urgent or emergent procedures may not permit delay, requiring clinicians to proceed while implementing strategies designed to minimize aspiration risk and optimize patient safety.

When proceeding with surgery in patients identified as having a potentially full stomach, anesthetic planning becomes especially important. Regional anesthesia and neuraxial anesthesia should be considered whenever clinically appropriate because these techniques may allow the procedure to be performed without exposing the patient to the risks associated with airway manipulation and loss of protective reflexes. However, patient factors, surgical requirements, and the likelihood of conversion to general anesthesia must be carefully evaluated before selecting these approaches.

If sedation is required, clinicians should avoid deep sedation in patients who have not been adequately fasted or who demonstrate significant residual gastric contents unless airway protection can be ensured. Deep sedation may impair airway reflexes and increase the likelihood of aspiration in vulnerable patients. When general anesthesia is necessary, rapid sequence induction remains one of the most widely accepted strategies for reducing aspiration risk. This approach aims to minimize the interval between loss of consciousness and airway protection by tracheal intubation, thereby reducing the opportunity for regurgitation and pulmonary aspiration.

In these circumstances, tracheal intubation is generally preferred over an unprotected airway technique. Endotracheal tubes provide a more secure airway and offer greater protection against aspiration compared with facemask ventilation, supraglottic airway devices, or deep sedation without airway control. Additional protective measures may include maintaining the patient in a head elevated position when feasible, ensuring immediate availability of suction equipment, and preparing for prompt management of regurgitation should it occur.

For patients with predominantly liquid gastric contents, gastric decompression may be considered when clinically appropriate. Nasogastric or orogastric tube placement can facilitate removal of liquid contents and potentially reduce gastric volume. However, clinicians should recognize the limitations of this intervention. Gastric suctioning does not guarantee complete stomach emptying, particularly when solid food particles, thick secretions, or particulate matter are present. Furthermore, insertion of gastric tubes carries procedural risks including discomfort, mucosal trauma, bleeding, malposition, and, in rare cases, perforation. Consequently, gastric decompression should be viewed as one component of a comprehensive risk reduction strategy rather than a substitute for sound clinical judgment.

Medication and Pharmacist Considerations

Pharmacists play an important role in perioperative risk assessment by identifying medications and medical conditions that may contribute to delayed gastric emptying, nausea, vomiting, or increased aspiration risk. A thorough medication review can uncover factors that may influence gastric ultrasound findings and assist in perioperative decision making. Several commonly prescribed medications are known to affect gastrointestinal motility. Glucagon-like peptide 1 receptor agonists have received particular attention because of their effects on gastric emptying and their widespread use in the management of diabetes and obesity. Opioids, anticholinergic medications, cannabinoids, dopamine agonists, tricyclic antidepressants, iron supplements, calcium preparations, and certain antipsychotic agents may also impair gastrointestinal motility or contribute to symptoms such as constipation, nausea, and delayed gastric transit.

The magnitude of these effects varies considerably among individuals and depends on multiple factors, including medication dose, duration of therapy, patient age, underlying gastrointestinal disorders, metabolic conditions such as diabetes, and other comorbid illnesses. Consequently, medication history should be interpreted within the broader clinical context rather than used as an isolated predictor of aspiration risk.

Pharmacologic interventions are sometimes considered in an attempt to reduce gastric contents or improve gastric emptying. Metoclopramide is one of the most commonly used prokinetic agents and may accelerate gastric emptying in selected patients. However, clinicians should avoid viewing metoclopramide as a simple or universally effective solution for a full stomach. Its use requires careful consideration of potential adverse effects and contraindications. Metoclopramide carries a boxed warning regarding the risk of tardive dyskinesia, particularly with prolonged use. Additional adverse effects include extrapyramidal symptoms, akathisia, sedation, diarrhea, depression, and worsening of Parkinsonian symptoms. Dose adjustment may be necessary in patients with renal impairment, and the medication should be avoided in individuals with bowel obstruction or other contraindications to enhanced gastrointestinal motility.

Ondansetron is frequently administered to reduce perioperative nausea and vomiting and may improve patient comfort. However, it is important to recognize that ondansetron does not promote gastric emptying and therefore does not address the underlying issue of residual gastric contents. While effective as an antiemetic, its use requires awareness of potential cardiac effects, particularly QT interval prolongation. Patients with congenital long QT syndrome, electrolyte abnormalities such as hypokalemia or hypomagnesemia, heart failure, bradyarrhythmias, or concomitant use of other QT prolonging medications may require additional monitoring and risk assessment.

Acid suppression strategies may also be incorporated into perioperative aspiration risk reduction protocols. Histamine 2 receptor antagonists and proton pump inhibitors can decrease gastric acidity, potentially reducing the severity of aspiration pneumonitis should aspiration occur. Nonparticulate antacids may similarly increase gastric pH and decrease the harmful effects of aspirated gastric fluid. Nevertheless, these interventions do not remove gastric contents or eliminate aspiration risk. They should not be presented as substitutes for appropriate fasting, airway management, or procedural planning. Instead, pharmacologic prophylaxis should be reserved for selected higher risk patients in accordance with institutional policies and anesthesia guidelines.

Ultimately, management of the patient with a gastric ultrasound suggesting a full stomach requires a multidisciplinary, individualized approach that integrates sonographic findings with clinical judgment. Decisions regarding procedural delay, anesthetic technique, airway protection, pharmacologic intervention, and gastric decompression should be guided by the urgency of the procedure and the patient’s overall risk profile. When incorporated into a comprehensive perioperative assessment strategy, gastric ultrasound provides valuable information that can improve patient safety, inform anesthetic decision making, and help reduce the incidence of aspiration related complications.

Table 2. Medication Issues Relevant to Gastric Ultrasound and Aspiration Risk

Medication or class	Clinical relevance	Practical caution
GLP-1 receptor agonists and dual incretin agents	May delay gastric emptying, especially with dose escalation or GI symptoms	Risk-stratify; most patients do not require automatic discontinuation
Opioids	Delay gastric emptying, increase nausea, impair airway reflexes	Use multimodal analgesia and reassess sedation risk
Anticholinergics	May worsen gastric stasis, constipation, urinary retention, delirium	Avoid unnecessary anticholinergic burden in older or high-risk patients
Metoclopramide	Prokinetic and antiemetic	Boxed warning for tardive dyskinesia; monitor for EPS, akathisia, sedation, renal dosing
Ondansetron	Antiemetic but not prokinetic	QT prolongation risk; monitor high-risk patients and electrolytes
H2 blockers and PPIs	Reduce gastric acidity	Do not reduce solid content or guarantee aspiration protection
Nonparticulate antacids	Reduce acidity immediately	May increase gastric volume; use selectively
Cannabinoids	May contribute to nausea, vomiting, or altered gastric motility in some patients	Ask specifically, especially in emergency and ambulatory settings

Table 3. When Gastric Ultrasound Is Most Likely to Add Value

Scenario	Usefulness	Rationale
Healthy elective patient with reliable fasting history	Usually low	Guidelines and clinical history are usually sufficient
Uncertain or unreliable fasting history	High	Ultrasound can provide objective bedside information
Emergency surgery	High	Waiting for fasting interval may not be possible
Active labor or urgent cesarean delivery	High in selected cases	Gastric emptying and urgency are less predictable
Diabetes with symptoms or suspected gastroparesis	High	Fasting duration may not reflect emptying
GLP-1 receptor agonist use with GI symptoms or dose escalation	Moderate to high	Supports individualized risk assessment
GERD alone without other risk factors	Usually low	Reflux symptoms do not necessarily mean retained gastric contents
Enteral feeding or recent tube feeds	Moderate to high	May help when timing and emptying are uncertain
Prior gastric surgery	Variable	Anatomy may limit standard interpretation
Indeterminate scan	No reassurance	Manage according to clinical risk

Table 4. Suggested Local Implementation Framework

Program element	Minimum standard	Why it matters
Indications	Define patient groups where scanning is appropriate	Prevents indiscriminate scanning
Credentialing	Supervised scans plus image review before independent use	Reduces false reassurance and misclassification
Documentation	Record indication, position, qualitative grade, estimated volume when used, limitations, and management decision	Supports clinical accountability
Quality assurance	Periodic image review and complication or aspiration-event review	Maintains reliability over time
Workflow	Decide whether scans occur in preop, ED, labor and delivery, ICU, or procedure suite	Prevents delays and unclear ownership
Escalation pathway	Define actions for full stomach, indeterminate study, or failed scan	Ensures ultrasound results change care appropriately
Pharmacy integration	Medication review for GLP-1 agents, opioids, anticholinergics, prokinetics, antiemetics, and QT-risk drugs	Connects imaging findings with modifiable aspiration risks

Training and Quality Assurance

Implementation requires more than buying a handheld ultrasound device. Operators need training in image acquisition, antral identification, qualitative grading, measurement technique, and documentation. Qualitative assessment is generally easier to learn than quantitative volume estimation.

A safe program should define who may perform the scan, how many supervised studies are required, how images are stored, how indeterminate exams are documented, and what actions follow each result. Quality assurance should include image review, feedback, and ongoing competency assessment.

Gastric ultrasound should be embedded into workflow only where it answers a real question. A preoperative holding-area model may be useful for elective high-risk patients. Emergency department or operating-room assessment may be more appropriate for urgent procedures. Routine scanning of every elective patient may create delays without proven outcome benefit.

Limitations

Gastric ultrasound has important limitations. Image acquisition may be difficult in severe obesity, bowel gas, altered anatomy, late pregnancy, agitation, pain, inability to tolerate positioning, or prior gastric surgery. Volume formulas may not apply to all populations. A technically limited study should not reassure the clinician.

The largest evidence gap is clinical outcome benefit. Most available studies evaluate diagnostic accuracy, residual gastric content, aspiration-risk classification, or management change. Aspiration is rare, so very large studies would be needed to prove reduction in aspiration events. Until that evidence exists, claims about improved patient safety should be careful and measured.

References

American Society of Anesthesiologists. (2017). Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. Anesthesiology, 126(3), 376-393.

American Society of Anesthesiologists Task Force. (2023). Practice guidelines for preoperative fasting: Carbohydrate-containing clear liquids with or without protein, chewing gum, and pediatric fasting duration. Anesthesiology, 138(2), 132-151.

ASRA Pain Medicine. (2025). Gastric point-of-care ultrasound narrative review and expert practice recommendations for aspiration risk assessment in medically complex patients.

Bataille, A., Rousset, J., Marret, E., & Bonnet, F. (2019). Ultrasonography for gastric content assessment in the perioperative period: A systematic review. European Journal of Anaesthesiology, 36(10), 747-754.

Bouvet, L., Zieleskiewicz, L., Loubradou, E., Allaouchiche, B., Beuve, M., Jacquot, C., et al. (2014). Reliability of gastric suctioning compared with ultrasound assessment of gastric content. Anaesthesia, 69(9), 1028-1034.

Kindel, T. L., Wang, A. Y., Wadhwa, A., et al. (2024). Multisociety clinical practice guidance for the safe use of GLP-1 receptor agonists in the perioperative period.

Kruisselbrink, R., Arzola, C., Endersby, R., Tse, C., Chan, V., & Perlas, A. (2017). Intra- and interrater reliability of ultrasound assessment of gastric volume. Anesthesiology, 127(2), 315-322.

Pan, X., Chai, J., Gao, X., Li, S., Liu, J., Li, L., & Li, Z. (2024). Diagnostic performance of ultrasound in the assessment of gastric contents: A systematic review and meta-analysis. Insights into Imaging.

Perlas, A., Chan, V. W. S., Lupu, C. M., Mitsakakis, N., & Hanbidge, A. (2009). Ultrasound assessment of gastric content and volume. Anesthesiology, 111(1), 82-89.

Perlas, A., Mitsakakis, N., Liu, L., Cino, M., Haldipur, N., Davis, L., et al. (2013). Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination. Anesthesia & Analgesia, 116(2), 357-363.

Perlas, A., Van de Putte, P., Van Houwe, P., & Chan, V. W. S. (2016). I-AIM framework for point-of-care gastric ultrasound. British Journal of Anaesthesia, 116(1), 7-11.

Schmitz, A., Thomas, S., Melanie, F., Rabia, L., Christoph, E., Luc, H., & Walid, H. (2016). Ultrasonographic gastric antral area and gastric contents volume in children. Paediatric Anaesthesia, 26(11), 1071-1077.

U.S. National Library of Medicine. DailyMed prescribing information for metoclopramide and ondansetron. Accessed: June 2026.

Van de Putte, P., & Perlas, A. (2014). Ultrasound assessment of gastric content and volume. British Journal of Anaesthesia, 113(1), 12-22.

Van de Putte, P., Vernieuwe, L., Jerjir, A., Verschueren, L., Tacken, M., & Perlas, A. (2018). When fasted is not empty: A retrospective cohort study of gastric content in fasted surgical patients. British Journal of Anaesthesia, 120(4), 735-741.